Registration Dossier

Diss Factsheets

Administrative data

Endpoint:
basic toxicokinetics, other
Type of information:
other: expert statement
Adequacy of study:
key study
Study period:
2021
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
other company data
Title:
Unnamed
Year:
2021
Report date:
2021

Materials and methods

Objective of study:
toxicokinetics
Test guideline
Qualifier:
according to guideline
Guideline:
other: according to ECHA Guidance R.7c, June 2017, v.3

Test material

1
Chemical structure
Reference substance name:
[x Sodium, y Potassium, z Lithium, x+y+z =2] 4-amino-3-[[[(2,4-diaminophenyl)diazenyl]phenyl]diazenyl]-5-hydroxy-6-(phenyldiazenyl)naphthalene-2,7-disulfonate
EC Number:
824-263-3
Cas Number:
2196165-14-5
Molecular formula:
C28H21N9O7S2.xNa.yK.zLi
IUPAC Name:
[x Sodium, y Potassium, z Lithium, x+y+z =2] 4-amino-3-[[[(2,4-diaminophenyl)diazenyl]phenyl]diazenyl]-5-hydroxy-6-(phenyldiazenyl)naphthalene-2,7-disulfonate

Results and discussion

Main ADME results
Type:
absorption
Results:
estimated for risk assessement purposes: oral 50%; dermal 50%; inhalation 50%

Applicant's summary and conclusion

Conclusions:
No bioaccumulation potential determined based on available data and qualitative assessment according to ECHA Guidance R.7c, June 2017, v.3